Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the detailed record of transactions filed by Guggenhime Andrew, Director Financiero. Director active across 1 company, notably Vaxcyte, Inc.. Aggregated, 52 filings have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €968k. History available since 18 November 2021. The latest transaction was disclosed on 3 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Guggenhime Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8000 títulos@ 5,35 US$1.5% de su flujoCommon StockSEC:0001649094-24-000038:0
25 de 52 declaraciones
About Guggenhime Andrew
GUGGENHIME ANDREW is Directeur Financier at Vaxcyte, Inc. (PRESIDENT AND CFO). He has 49 filings in total, and across the recent sample of 49 filings, the transactions run from 2021-11-22 to 2026-07-06, with EUR 0 in buys and EUR 500831 in sells. The most common transaction type is Levée d'options.